Director, Principal Medical Writer, Europe

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The companys R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The companys RAS(ON) inhibitors daraxonrasib (RMC-6236) a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291) a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805) a RAS(ON) G12D-selective inhibitor; and RMC-5127 a RAS(ON) G12V-selective inhibitor are currently in clinical development. As a new member of the Revolution Medicines team you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

The Opportunity:

As part of our expanding European organization we are seeking an experienced Principal Regulatory Medical Writer to support the preparation of high-quality regulatory documentation for clinical development and marketing authorization activities across Europe. Working closely with Regulatory Affairs Clinical Development Clinical Operations Biometrics Pharmacovigilance CMC and other cross-functional teams the successful candidate will author coordinate and finalize regulatory documents supporting interactions with European and international Health Authorities.

The candidate will serve as the lead author for complex regulatory documents and will ensure documents are scientifically accurate strategically aligned compliant with ICH EU and applicable regional requirements and submission-ready.

The successful candidate will play a key role in supporting regulatory interactions with European Health Authorities by developing clear scientifically robust and strategically aligned regulatory documentation throughout the product lifecycle.

The role will report to the VP Regulatory Affairs Europe.

Primary Responsibilities:

• Author edit and coordinate high-quality clinical regulatory documents including:

• Responses to Health Authority questions (EMA MHRA Swissmedic etc).

• Scientific Advice briefing books and meeting packages.

• Risk Management Plan (RMP).

• Periodic safety documents (as applicable).

• As needed serve as a medical writing lead for complex clinical regulatory documents supporting clinical development including protocols IBs CSRs and CTA modules.

• Other regulatory documents supporting lifecycle management variations and renewals.

• Coordinate preparation of responses to regulatory agency requests for information ensuring consistency across multidisciplinary functional contributions.

• Lead document planning review cycles comment resolution and finalization while ensuring adherence to project timelines.

• Collaborate closely with Global and European Regulatory Affairs to ensure documents support the overall regulatory strategy.

• Ensure all documents comply with applicable ICH guidelines EMA guidance GCP company standards and document templates.

• Facilitate document review meetings and manage cross-functional comment adjudication.

• Identify potential scientific or regulatory inconsistencies and work with subject matter experts to resolve issues.

• Maintain consistency across related submission documents and across development programs.

• Support development and continuous improvement of medical writing processes templates style guides and standard operating procedures.

• Mentor junior writers when appropriate and contribute to departmental best practices.

The candidate must have a thorough understanding of oncology drug development applicableEuropean regulations and guidelines.

Required Skills Experience and Education:

• Advanced degree (PhD PharmD MD MSc or equivalent) in life sciences or a related scientific discipline.

• Minimum 10 years of regulatory medical writing experience within the biotechnology or pharmaceutical industry.

• Demonstrated experience authoring documents supporting European regulatory submissions.

• Experience preparing responses to Health Authority questions during CTA MAA or post-approval procedures.

• Thorough understanding of:

  • ICH guidelines (including E3 M4 E6)

  • EU Clinical Trial Regulation (EU CTR 536/2014)

  • EMA regulatory procedures

  • GCP principles

• Strong scientific writing and editing skills with exceptional attention to detail.

• Excellent project management and organizational skills.

• Ability to manage multiple simultaneous projects in a fast-paced environment.

• Strong interpersonal and communication skills with demonstrated ability to work across multidisciplinary global teams.

• Excellent written and verbal English.

Preferred Skills:

• Oncology regulatory writing experience.

• Experience supporting EMA Scientific Advice and/or Marketing Authorisation Applications.

• Experience with centralized decentralized or national European regulatory procedures.

• Experience with eCTD submissions.

• Familiarity with Veeva Vault RIM StartingPoint EndNote SmartSheet and document management systems.

• Experience performing quality control reviews of regulatory documents.

• Experience working within small or mid-sized biotechnology companies.

• Experience supporting European regulatory submissions.

Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect process and use any personal data that you provide to us in accordance with ourCCPA additional information please contact.

#LI-LO1 #LI-Hybrid

We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms email phone or text message.

Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information purchase equipment or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @ email address.

If you believe youve been contacted by someone impersonating a Revolution Medicines recruiter please report it to so we can share these impersonations with our IT team for tracking and awareness.